A prescription drug product shall not be assessed a fee under subparagraph (A) if such product is identified on the list compiled under section
355
(j)(7)(A) of this title with a potency described in terms of per 100 mL, or if such product is the same product as another product approved under an application filed under section
355
(b) or
355
(j) of this title, under an abbreviated application filed under section
357 of this title (as in effect on the day before November 21, 1997), or under an abbreviated new drug application pursuant to regulations in effect prior to the implementation of the Drug Price Competition and Patent Term Restoration Act of 1984.